Go Pro

Billiontoone (BLLN) Competitors

Billiontoone logo
$128.40 +3.53 (+2.83%)
As of 01:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BLLN vs. BTSG, FMS, HIMS, PACS, and RDNT

Should you buy Billiontoone stock or one of its competitors? MarketBeat compares Billiontoone with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Billiontoone include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and RadNet (RDNT). These companies are all part of the "healthcare" industry.

How does Billiontoone compare to BrightSpring Health Services?

Billiontoone (NASDAQ:BLLN) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Billiontoone presently has a consensus target price of $126.00, suggesting a potential downside of 2.06%. BrightSpring Health Services has a consensus target price of $70.12, suggesting a potential upside of 1.93%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts plainly believe BrightSpring Health Services is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
3.00

BrightSpring Health Services has higher revenue and earnings than Billiontoone. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$354.54M16.69$7.45M$0.55233.91
BrightSpring Health Services$12.91B1.05$190.67M$1.4148.79

In the previous week, BrightSpring Health Services had 1 more articles in the media than Billiontoone. MarketBeat recorded 16 mentions for BrightSpring Health Services and 15 mentions for Billiontoone. BrightSpring Health Services' average media sentiment score of 0.49 beat Billiontoone's score of 0.32 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
BrightSpring Health Services
4 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BrightSpring Health Services has a net margin of 2.27% compared to Billiontoone's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
BrightSpring Health Services 2.27%14.63%4.41%

Summary

BrightSpring Health Services beats Billiontoone on 12 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, indicating a potential upside of 16.35%. Billiontoone has a consensus price target of $126.00, indicating a potential downside of 2.06%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.56
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Billiontoone had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 15 mentions for Billiontoone and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.30 beat Billiontoone's score of 0.32 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Billiontoone. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$19.36B0.67$1.11B$1.9012.67
Billiontoone$354.54M16.69$7.45M$0.55233.91

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Billiontoone's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Billiontoone N/A N/A N/A

Summary

Fresenius Medical Care AG & Co. KGaA beats Billiontoone on 9 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

In the previous week, Billiontoone had 5 more articles in the media than Hims & Hers Health. MarketBeat recorded 15 mentions for Billiontoone and 10 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.69 beat Billiontoone's score of 0.32 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Billiontoone
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hims & Hers Health has higher revenue and earnings than Billiontoone. Hims & Hers Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B3.62$128.37M-$0.09N/A
Billiontoone$354.54M16.69$7.45M$0.55233.91

Billiontoone has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Billiontoone N/A N/A N/A

Hims & Hers Health presently has a consensus target price of $30.70, indicating a potential downside of 16.29%. Billiontoone has a consensus target price of $126.00, indicating a potential downside of 2.06%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Billiontoone beats Hims & Hers Health on 8 of the 15 factors compared between the two stocks.

How does Billiontoone compare to PACS Group?

PACS Group (NYSE:PACS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

In the previous week, Billiontoone had 6 more articles in the media than PACS Group. MarketBeat recorded 15 mentions for Billiontoone and 9 mentions for PACS Group. PACS Group's average media sentiment score of 0.51 beat Billiontoone's score of 0.32 indicating that PACS Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group has higher revenue and earnings than Billiontoone. PACS Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.34$191.54M$1.5628.79
Billiontoone$354.54M16.69$7.45M$0.55233.91

PACS Group has a net margin of 4.49% compared to Billiontoone's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Billiontoone N/A N/A N/A

PACS Group presently has a consensus target price of $50.60, indicating a potential upside of 12.65%. Billiontoone has a consensus target price of $126.00, indicating a potential downside of 2.06%. Given PACS Group's stronger consensus rating and higher probable upside, analysts clearly believe PACS Group is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

PACS Group beats Billiontoone on 9 of the 13 factors compared between the two stocks.

How does Billiontoone compare to RadNet?

RadNet (NASDAQ:RDNT) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Billiontoone has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.42-$18.65M-$0.18N/A
Billiontoone$354.54M16.69$7.45M$0.55233.91

In the previous week, Billiontoone had 11 more articles in the media than RadNet. MarketBeat recorded 15 mentions for Billiontoone and 4 mentions for RadNet. RadNet's average media sentiment score of 1.17 beat Billiontoone's score of 0.32 indicating that RadNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Billiontoone has a net margin of 0.00% compared to RadNet's net margin of -0.66%. RadNet's return on equity of 2.77% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.66% 2.77% 0.97%
Billiontoone N/A N/A N/A

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

RadNet currently has a consensus price target of $87.43, suggesting a potential upside of 39.00%. Billiontoone has a consensus price target of $126.00, suggesting a potential downside of 2.06%. Given RadNet's stronger consensus rating and higher probable upside, research analysts clearly believe RadNet is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

RadNet beats Billiontoone on 9 of the 15 factors compared between the two stocks.

Get Billiontoone News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLLN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLLN vs. The Competition

MetricBilliontooneServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$5.92B$2.08B$20.33B$12.62B
Dividend YieldN/AN/A5.14%8.43%
P/E Ratio233.9326.3819.4924.39
Price / Sales16.696.4437.8991.34
Price / Cash380.782,074.30351.4659.39
Price / Book12.2829.5211.906.31
Net Income$7.45M-$30.36M-$15.57M$331.45M
7 Day Performance6.67%0.03%1.20%0.26%
1 Month Performance23.76%7.12%-1.25%-0.64%
1 Year PerformanceN/AN/A-9.24%20.24%

Billiontoone Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLLN
Billiontoone
1.812 of 5 stars
$128.40
+2.8%
$126.00
-1.9%
N/A$5.93B$354.54M234.23620
BTSG
BrightSpring Health Services
3.2345 of 5 stars
$69.03
flat
$63.67
-7.8%
+243.0%$13.62B$12.91B48.9623,500
FMS
Fresenius Medical Care AG & Co. KGaA
4.3168 of 5 stars
$23.55
+0.1%
$28.00
+18.9%
-11.1%$12.64B$22.20B12.391,488
HIMS
Hims & Hers Health
3.0425 of 5 stars
$36.75
-0.1%
$30.63
-16.6%
-32.4%$8.52B$2.35BN/A2,442
PACS
PACS Group
3.1589 of 5 stars
$44.61
+0.3%
$48.00
+7.6%
+246.7%$7.04B$5.29B28.5947,455

Related Companies and Tools


This page (NASDAQ:BLLN) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners